Jubilant’s Big Pharma Play—Unlocking Hidden Value or a Strategic Gamble?

Unknown Apr 02, 2026 950 Views

Jubilant Pharmova Ltd. has approved the sale and transfer of its Active Pharmaceutical Ingredients (API) business to its wholly owned subsidiary, Jubilant Biosys Limited, under a slump sale agreement. The move is aimed at streamlining operations, enhancing efficiency, and unlocking value within t...